VIEWPOINTS Carsten Linnemann, CEO at Neogene Therapeutics Shares Insights on the Approval of CTA for the P-I Trial of its TCR Therapy to Treat Solid TumorsBySenior EditorSeptember 7, 20220Comments
VIEWPOINTS John Strickler, Associate Professor of Medicine, Duke University School of Medicine, Shares Insights from the P-II Study at the 2022 ESMO World Congress on Gastrointestinal CancerBySenior EditorSeptember 6, 20220Comments
VIEWPOINTS George Stanley, Medical Director for the UK & Ireland at BioCryst Shares Insights from Long-Term Study Data at EAACI 2022BySenior EditorAugust 31, 20220Comments
VIEWPOINTS Jeff Stein, President & CEO of Cidara Therapeutics Shares Insights on the P-III ReSTORE Trial of Rezafungin to Treat CandidemiaBySenior EditorAugust 30, 20220Comments
VIEWPOINTS Rami Apelian and Marija Geertsen Share Insights from 9 Poster Presentations on Migraine Prevention & Treatment at AHS 2022BySenior EditorAugust 29, 20220Comments
INSIGHTS+ Top Performing Drug of 2021 – Stelara (August Edition)BySenior EditorAugust 25, 20220Comments
VIEWPOINTS Jeremiah Robison, Founder, and CEO of Cionic Shares Insights on the Collaboration with Yves Behar’s fuseproject for the Cionic Neural SleeveBySenior EditorAugust 24, 20220Comments
